1. Home
  2. MBUU vs RLMD Comparison

MBUU vs RLMD Comparison

Compare MBUU & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Malibu Boats Inc.

MBUU

Malibu Boats Inc.

N/A

Current Price

$20.09

Market Cap

397.4M

Sector

Industrials

ML Signal

N/A

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

N/A

Current Price

$4.28

Market Cap

348.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBUU
RLMD
Founded
1982
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.4M
348.8M
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
MBUU
RLMD
Price
$20.09
$4.28
Analyst Decision
Buy
Strong Buy
Analyst Count
10
4
Target Price
★ $32.13
$10.75
AVG Volume (30 Days)
307.9K
★ 1.6M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 45.28
EPS
★ 0.30
N/A
Revenue
★ $914,590,000.00
$13,070.00
Revenue This Year
$21.52
N/A
Revenue Next Year
$7.54
N/A
P/E Ratio
$68.17
★ N/A
Revenue Growth
13.25
★ 154.83
52 Week Low
$19.46
$3.07
52 Week High
$34.97
$8.00

Technical Indicators

Market Signals
Indicator
MBUU
RLMD
Relative Strength Index (RSI) 37.21 61.54
Support Level $19.46 $4.19
Resistance Level $23.65 $4.53
Average True Range (ATR) 1.02 0.30
MACD -0.24 0.11
Stochastic Oscillator 10.65 77.54

Price Performance

Historical Comparison
MBUU
RLMD

About MBUU Malibu Boats Inc.

Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Most recently, in 2026, it tied up with Saxdor Yachts, focused on adventure dayboats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: